Affymax and Takeda Pharmaceutical have recalled Omontys, or peginesatide, following reports of serious allergic reactions and three deaths. The drug is used to treat anemia in patients undergoing kidney dialysis. Three deaths and 16 other cases of severe reactions have been reported, according to the FDA.
Recall of anemia drug follows reports of allergic reactions, deaths
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||